What they found
Mounting evidence links PFAS exposure to adverse pulmonary outcomes like asthma, allergies, infections, and cancer. Studies show PFAS modulate inflammation, oxidative stress, mucus production, and epithelial barrier integrity in lung cells.
What they studied
This review summarized findings from human clinical/epidemiological, animal, and in vitro investigations on PFAS exposure and lung health. Most data originated from oral/ingestion exposure designs, not volatilized or aerosolized PFAS.
Takeaways
The abstract focuses on findings regarding PFAS exposure and lung health; it does not provide personal how-to steps for individuals.
About this paper
This is a review article summarizing existing literature on PFAS exposure and lung cell biology. It highlights that while datasets link PFAS to adverse pulmonary outcomes, most studies used oral/ingestion exposure designs, not volatilized or aerosolized PFAS. There is a general lack of data for dose-response modeling and risk characterization, representing gaps in assessing pulmonary health risks.